BioNano Genomics (BNGO) has provided an update.
Bionano Genomics, Inc. has struck a deal with institutional investors to sell over 11 million shares and warrants in a market-priced registered direct offering, aiming to raise around $10 million before fees and expenses. Accompanying each share and warrant sold is the right to purchase additional shares at $0.571. The proceeds are intended for general corporate purposes, including research and capital expenses. The offering, managed by H.C. Wainwright & Co. as the exclusive placement agent, is set to close on July 8, 2024, provided conditions are met.
Learn more about BNGO stock on TipRanks’ Stock Analysis page.
